NewsRx

Search our medical news database

FDA Law Weekly

Susan Hasty, Publisher

Table of Contents . . . September 22nd, 2005

Non-Subscriber - Summaries Only

Related Areas: Other Issues in FDA Law Weekly | Other Publications

Abaxis - CLIA waived status reported for analytes when used with Piccolo analyzer

Abbott Laboratories - U.S. FDA grants clearance to market blood glucose monitoring system

Advanced Medical Institute - Dr. Jack Vaisman receives Australian patent for PE therapy

Alcon - Nevanac gets U.S. FDA approval for pain associated with cataract surgery

Allergan - New formulation of Alphagan P receives U.S. FDA approval

Alliance for Better Bone Health - U.S. FDA approves prescription risedronate with calcium tabs for osteoporosis

Allon Therapeutics - Alzheimer drug maker reports clinical update, $0.05 per share loss

Antisoma - Antisoma granted U.S. orphan drug status for AS1411 in renal cancer

Anulex Technologies - U.S. FDA 510(k) clearance granted for the Inclose surgical mesh system

Ariad Pharmaceuticals - Orphan drug designations granted for AP23573

Arpida - Intravenous iclaprim granted fast track status by U.S. FDA

Array BioPharma - Anticancer compound cleared to advance into human clinical trials

Auburn University - Acamprosate for treatment of alcohol dependence reviewed

Barco - Flat panel display added to PACS display solutions

BioView - U.S. FDA clears Duet System for automated FISH scanning

ABC Foundation School of Medicine, Sao Paulo - Complementary and alternative medicine used by Brazilian oncologists

Albert Einstein College of Medicine - Further research needed on HIV in an aging population

Altnagelvin Area Hospital, Londonderry - Experience recommended for performing D2 gastrectomy

Amgen - Biotech company names David R. Parkinson VP

Amylin Pharmaceuticals - Phase 2 study of long acting Byetta released

Anadys Pharmaceuticals - Study of isatoribine in hepatitis C demonstrates proof of concept

Ankara University - Outcome of dentoalveolar distraction evaluated in canine model

AstraZeneca - In vitro device enables analysis of shear-induced drug release in fed stomach

Austin Health Hospital, Heidelberg - Thalidomide arrests colorectal cancer metastasis without affecting angiogenesis

Azienda Hospital Careggi, Florence - Low-protein diets may help prevent CV disease in patients with ESRD

Basil-Gerald Felsenstein Med. Center, Petah Tikva - Vitamin D sensitized breast cancer cells to H2 O2

Baylor College of Medicine, Houston - Biomarkers related to obesity and metabolic syndrome analyzed

BioDelivery Sciences International - Drug delivery company names Mark Sirgo as CEO

Bionomics - Australian biotech company reports operating loss of AU$4.632M

Burnham Institute - Apoptosis-based therapies for hematologic malignancies discussed

CHU Lille - Recent findings in hematology described

CHUR Dupuytren - Recent findings illuminate research in human papillomavirus vaccines

California Physical Therapy Association - California physical therapists offer help to those suffering from pain

Caraco Pharmaceutical Laboratories - U.S. FDA grants approval for additional Clozapine strength

Cerenis Therapeutics SA - Pharma completes $30.5M financing to progress drugs for heart diseases

Changzheng Hospital, Shanghai - 2-Methoxyestradiol at low dose induced differentiation of myeloma cells

China Medical University, Taichung City - Induced aortic relaxation studied, role of cGMP signals defined

Cima Labs - OraSolv technology used in Clarinex (desloratadine)

CryoCor - Company reports progress in U.S. FDA review of atrial flutter PMA

Crystal Clinic, Akron - Synthes Modular Hand Set not suitable for use in first MTPJ arthrodesis

CytRx Corp. - U.S. FDA issues explanation on phase II study of ALS drug

Dana Farber Cancer Institute - Researchers report details of new studies and findings in the area of cancer vaccines

Diet & Nutrition - HealthAllies offers deals on Jenny Craig

Duke University, Durham - Engineered chromosomes not yet viable gene-delivery platforms

Duke University, Durham - Vaccine development for gastric cancer and Helicobacter reviewed

Duska Therapeutics - ATP developer reports Q2 net loss of $559,473

EPIX Pharmaceuticals - Studies conclude MS-325 (Vasovist) improves imaging in MRA

Emergent BioSolutions - BioThrax maker expands global marketing reach

EntreMed - Disease-modifying activity of 2ME2 demonstrated in preclinical RA studies

Federal University of Sao Paulo - Rosuvastatin is most effective for achieving LDL-C goals

Finance - Active drug delivery company reports 7% decrease in sales

Franz Volhard Clinic Research Center, Berlin - Reports describe recent advances in obesity and diabetes research

GlycoGenesys - Carbohydrate drug-development company comments on Q2 loss

Goethe-University, Frankfurt -  C. elegans studied, nicotinic receptor-associated proteins identified

Guidant Corp. - Company announces full availability of cardiac rhythm management product line

Guidant Corp. - Company gets approval to expand U.S. drug-eluting stent trial

HaptoGuard - IND filed for BXT-51072 for diabetics at risk for cardiovascular complications

Harris Interactive - U.S. adults only moderately concerned about avian flu, but endorse preparation

ID Biomedical Corp. - DNA diagnostic test maker reports loss of CDN $0.75 per share

Legal Issues - Chamber of Commerce group lauds Illinois medical liability reforms

NeoPharm - U.S. FDA approves special protocol assessment for phase III PRECISE trial

Neurobiological Technologies - U.S. FDA agrees on design of Viprinex trial, Xerecept trial enrollment announced

Novavax - Positive preclinical results reported on vaccine for pandemic influenza

Pharsight Corp. - Clinical drug development software provider releases DMX 1.4 server

Public Health Agency of Canada - Effects of Ebola virus glycoproteins on endothelial cell activation outlined

St. Jude Medical, Inc. - First U.S. double implant of new heart valve reported

Teva Pharmaceutical Industries - Generic drug company gets tentative approval of antinauseant, antiemetic agent

U.S. Food & Drug Administration - New findings in the area of immunology described

U.S. Food & Drug Administration - Semicarbazide in bread products measured by LC-MS

Utah Medical Products - Medical devices company notified that U.S. FDA lawsuit trial start postponed

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook